Effects of Early Thyroxine Treatment on Development and Growth at Age 10.7 Years: Follow-Up of a Randomized Placebo-Controlled Trial in Children With Down's Syndrome | Zendy

Jan Pieter Marchal | Zendy; Heleen MauriceStam | Zendy; Nadine A. Ikelaar | Zendy; Femke C. C. Klouwer | Zendy; Kim W. J. Verhorstert | Zendy; M Emma Witteveen | Zendy; Bregje A. Houtzager | Zendy; Martha A. Grootenhuis | Zendy; A.S. Paul van Trotsenburg | Zendy

Open Access

Effects of Early Thyroxine Treatment on Development and Growth at Age 10.7 Years: Follow-Up of a Randomized Placebo-Controlled Trial in Children With Down's Syndrome

Author(s) -

Jan Pieter Marchal,

Heleen MauriceStam,

Nadine A. Ikelaar,

Femke C. C. Klouwer,

Kim W. J. Verhorstert,

M Emma Witteveen,

Bregje A. Houtzager,

Martha A. Grootenhuis,

A.S. Paul van Trotsenburg

Publication year - 2014

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2014-2849

Subject(s) - placebo , randomized controlled trial , medicine , gross motor skill , pediatrics , motor skill , psychiatry , alternative medicine , pathology

In 2-year-old children with Down's syndrome (DS), early T4 treatment was found to result in slightly better motor development and growth.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research